Scott Bluni > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
Goodwin
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Scott Bluni
+1 617 570 1125 [email protected]
Position
Partner
Career
Scott Bluni is an experienced intellectual property attorney focused on counseling clients in patent-related matters such as strategic portfolio development, infringement avoidance, due diligence, enforcement, licensing, and other technology transactions. Dr. Bluni leverages his experiences as a former patent examiner and chief intellectual property counsel at a large, international medtech corporation to bring a pragmatic, solution-based approach to his practice.
Dr. Bluni has been recognized by Chambers USA: America’s Leading Lawyers for Business, Super Lawyers Massachusetts, LMG Life Sciences, and Managing IP – IP Stars.
Education
JD, 1998, The George Washington University Law School / PhD, Materials Science and Engineering, 1994, Lehigh University / MS, Materials Science and Engineering, 1992, Lehigh University / BS, Metallurgical Engineering, 1989, Lafayette College
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation